David Schaack (@dvidschaack) header
David Schaack (@dvidschaack) profile picture

Cardiac Electrophysiologist at #CCB Frankfurt, Germany. Studying computer science. Passionate about ECGs, #FOAMed and coffee (in no particular order).

Hessen, Deutschland
Joined May 2010
Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)Photo by David Schaack (@dvidschaack)
David Schaack retweeted
ULYSSES trial: Ultrasound-guided venous access significantly reduces vascular complications and arterial punctures during atrial fibrilation ablation vs conventional approach. Time to move from optional to standard of care. Read more in #EHJ. doi.org/10.1093/eurheartj/eh… #AF #echo #vascularcomplication #cardiotwitter @ESC_Journals @escardio
1
20
4
45
29,199
#EHRASnacks episode on Late‑Breaking Science: ablation and drug therapy at #EHRA26 @Dominik_Linz is joined by @VKutyifa and @dvidschaack to discuss: 🔹 BIO‑LIBRA study 🔹 ULYSSES – ultrasound‑guided puncture for AF ablation
9
15
1,930
David Schaack retweeted
🚨Latest #FreeRead in @JICE_EP Pulsed Field Ablation of the Cavotricuspid Isthmus Using a Balloon-in-Basket System 🧐📖rdcu.be/eBqS5 by Joseph A Kheir, @LukasUrbanek11, Andrea Urbani, @Mel_Gunawardene, Alexandra Marx, @jalurz, @dvidschaack, Matteo Rocchetti, Soroosh Najafi, Alexandra Steyer, @jongichun & Boris Schmidt #EPeeps
10
22
2,875
David Schaack retweeted
#EHRA2025 #JACCCEP: First published data on the olive ablation strategy for the pentaspline PFA catheter. In this study, the novel strategy significantly improved PVI durability. jacc.org/doi/10.1016/j.jacep… #epAblation #EPeeps @dvidschaack @ShaojieChen1
17
1
47
7,942
Thrilled to share that the EMBOL-AF Registry (>450 embolic complications of AF ablation) has been accepted for a LBCT session at EHRA 2025! There's still time to contribute your experience—join us in this important research! sites.google.com/view/embol-… #EHRA2025 #AFib #EPeeps
3
19
1
44
5,155
David Schaack retweeted
Latest #FreeRead in @JICE_EP First Dual-Energy (Radiofrequency and Pulsed-Field Ablation) Successful Bailout VT Ablation despite Coronary Laceration 🧐📖 rdcu.be/d3cYf by Alexandra Steyer, @dvidschaack , Shota Tohoku, Andrea Urbani, Joseph Antoine Kheir, @LukasUrbanek11, @bordistef, @BorisSchmidt5 & @jongichun #EPeeps
9
23
2,572
Dr @jongichun and @dvidschaack demonstrate the Affera system, showcasing real-time catheter positioning, pacing checks, and precise ablation. The team highlights significant findings and successful results, emphasising the system’s advanced mapping and ablation capabilities.
4
1
17
3,832
Das CCB lädt ins AMP ein! Dieses Mal zum EKG-Quiz mit dem Thema „Notfälle im EKG“. Wir freuen uns auf einen unterhaltsamen Abend! 📅 Mittwoch, 04.12.2024 📍 AMP, Frankfurt am Main ⏰ 18:00–20:00 Uhr 🎟 Teilnahme kostenlos! @YoungDgk @AGEP_DGK #EPeeps @BorisSchmidt5 @jongichun
2
5
9
938
David Schaack retweeted
Jetzt auf @Herzmedizin_de #AGEP_Paper_of_the_Month #ASTRO_AF von @ChristianHeeger AFib trotz isolierter PV nach PVI? ✅Schmidt B et al. #Circulation ✅Cryoballon LAAI vs. Substrat-Modifikation ✅Kein Unterschied pr. EP 12-Mo Rezidivfreiheit von VHF lnkd.in/e4P8fhdw
1
8
2
12
1,798
#epeeps! The #EHRA wants to hear from you! Are all complication of AF ablation the same? Is it correct to report the rate of complication without an objective evaluation of their severity? What is a major complication? Share your opinion with us! surveymonkey.com/r/EHRACompS…
1
13
2
14
5,257
David Schaack retweeted
🚨New #FreeRead in @JICE_EP Durable LAA isolation Combining PFA and Radiofrequency Linear Lesions in a Patient with Therapy Refractory Left Atrial Appendage Tachycardia 🧐📖rdcu.be/dOvFU by Andrea Urbani, Shota Tohoku, @bordistef, @dvidschaack, Jun Hirokami, @LukasUrbanek11, Joseph Antoine Kheir, @BorisSchmidt5 & @jongichun #EPeeps
7
1
25
4,798
David Schaack retweeted
🚨New #OpenAccess Article in @JICE_EP Severe ST-segment elevation and AV block during pulsed-field ablation due to vasospastic angina — a novel observation 📖🧐rdcu.be/dFLei @dvidschaack, Karin Plank, @bordistef, @LukasUrbanek11, Shota Tohoku, Jun Hirokami, @BorisSchmidt5 & @jongichun #EPeeps
8
1
22
5,253
David Schaack retweeted
Breakout Session ☕️☕️☕️ 😴😴😴Sedation and PFA⚡️⚡️⚡️⚡️ Practical Tipps and Tricks 🔨⚒️🧰 Dr Schaack and S Reder
4
24
1,168
David Schaack retweeted
🚨Latest #OpenAccess Article in @JICE_EP The Impact of Ultrasound-Guided Vascular Access for Catheter Ablation of Left Atrial Arrhythmias in a High-Volume Centre 🧐📖 doi.org/10.1007/s10840-024-0… by Amelie Krimphoff, @LukasUrbanek11, @bordistef, @dvidschaack, Shota Tohoku, @ShaojieChen1, @jongichun & @BorisSchmidt5 #EPeeps
11
22
3,301
#epeeps around #Frankfurt... Join us for a couple of ECGs and a couple of drinks!!! @dvidschaack @BorisSchmidt5 @jongichun @ViclouiseJ @LukasUrbanek11
4
17
1,797
David Schaack retweeted
🔜Join us at the PFA summit and EHRA 2024 in Berlin! Looking forward. 🦜Early bird registration! @EHRAPresident @AGEP_DGK @purerfellner @DrJasonAndrade @drjohnm @ChristianHeeger
Make the most of early registration fees and explore the interactive world of #EHRA2024 Keep your finger on the pulse of innovation and register now. Early bird ends 7 Feb! ⏰ bit.ly/48yDTsb #EHRA_ESC #ArrhythmiaResearch @EHRAPresident
7
20
5,988
Did you know that on April 6th, the day before the #EHRAcongress, the Pulse Field Ablation Summit will take place? Ensure you secure your spot as seating is limited!! @EHRApresident @jongichun @DavidDuncker escardio.org/Congresses-Even…
2
23
2
65
12,555
We are happy to start a new worldwide registry! 👉Arterial EMBOLism after catheter ablation of Atrial Fibrillation „EMBOL-AF study“ ❗️❗️❗️ @EHRAPresident @jongichun @SergioCastrejon @escardio @AGEP_DGK @purerfellner Be part of it❗️❗️ ❗️ 👇👇👇 sites.google.com/view/embol-…
1
9
29
2,686
David Schaack retweeted
In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 @AHAScience

10
482
79
1,174
409,905